Antigen presentation and interferon signatures in B cells driven by localized ablative cancer immunotherapy correlate with extended survival.
- Resource Type
- Article
- Source
- Theranostics; 2022, Vol. 12 Issue 2, p639-656, 18p
- Subject
- Language
- ISSN
- 18387640